Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.41 |
| ▸ | TYMP | P19971 | 2/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 4/20 | 0.38 |
| ▸ | PRKAG1 | P54619 | 2/20 | 0.36 |
| ▸ | PRKAA1 | Q13131 | 2/20 | 0.36 |
| ▸ | PRKAB1 | Q9Y478 | 2/20 | 0.36 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.36 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.36 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.36 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.36 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.36 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.36 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.36 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24878603 | 0.94 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL29581997 | 0.94 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL25873876 | 0.94 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL26535891 | 0.94 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL668595 | 0.94 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL31588239 | 0.93 | TYMP (0.42) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL2258922 | 0.92 | TYMP (0.43) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL17861065 | 0.92 | TYMP (0.42) | PRMT6TYMPPRKAG1PRKAA1PRKAB1 | |
| SCHEMBL24829612 | 0.92 | TYMP (0.41) | PRMT6TYMPP2RY12PRKAG1PRKAA1 | |
| SCHEMBL23668111 | 0.91 | TYMP (0.41) | PRMT6TYMPP2RY12PRKAG1PRKAA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8252919-B2 | 2′-hydroxy-protected ribonucleoside derivative and production method thereof | KANEKA CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20110009609-A1 | 2'-HYDROXY-PROTECTED RIBONUCLEOSIDE DERIVATIVE AND PRODUCTION METHOD THEREOF | KANEKA CORPORATION (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009609-A1 | 2'-HYDROXY-PROTECTED RIBONUCLEOSIDE DERIVATIVE AND PRODUCTION METHOD THEREOF | RNASEL, RNASEH1, NUDT1 | PRMT6 2485/4885TYMP 183/4885P2RY12 3020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.